Skip to main content
. 2020 Jul 29;583(7818):752–759. doi: 10.1038/s41586-020-2119-x

Extended Data Fig. 9. Fetal-enhancer-linked CG-DMRs.

Extended Data Fig. 9

a, Number of feDMRs predicted in each tissue from each stage. b, Positive rate in E11.5 tissues of elements that were experimentally validated as an enhancer (+) or not (−) in a given E11.5 tissue. Numbers indicate the number of VISTA elements. c, Positive rate (fraction of elements that are experimentally validated as enhancer in a given tissue) of DNA elements in VISTA enhancer browser (left), ones that do not overlap with feDMRs or H3K27ac peaks (middle), and those that do not overlap with feDMRs or H3K27ac peaks and do not show a high evolutionary PhyloP score (right). Numbers in parentheses indicate the number of VISTA elements. d, Left, percentage of putative enhancers from ref. 23 that overlap with feDMRs in each tissue sample. Right, percentage of feDMRs that overlap with putative enhancers from ref. 23.